Literature DB >> 20552079

Post-traumatic Back Pain Revealed as Tuberculous Spondylitis -A Case Report-.

Bum Suk Kim1, Jeong Hee Shin, Ho Sik Moon, Jin Young Chon, Choon Ho Sung.   

Abstract

Tuberculous spondylitis is a very rare disease, but it can result in bone destruction, kyphotic deformity, spinal instability, and neurologic complications unless early diagnosis and proper management are done. Because the most common symptom of tuberculous spondylitis is back pain, it can often be misdiagnosed. Atypical tuberculous spondylitis can be presented as a metastatic cancer or a primary vertebral tumor. We must make a differential diagnosis through adequate biopsy. A 30-year-old man visited our clinic due to back and chest pain after a recent traffic accident. About 1 year ago, he had successfully recovered from tuberculous pleurisy after taking anti-tuberculosis medication. We performed epidural and intercostal blocks but the pain was not relieved. For the further evaluation, several imaging and laboratory tests were done. Finally, we confirmed tuberculous spondylitis diagnosis with the biopsy results.

Entities:  

Keywords:  back pain; biopsy; differential diagnosis; tuberculous spondylitis

Year:  2010        PMID: 20552079      PMCID: PMC2884205          DOI: 10.3344/kjp.2010.23.1.74

Source DB:  PubMed          Journal:  Korean J Pain        ISSN: 2005-9159


  9 in total

1.  American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America: treatment of tuberculosis.

Authors:  Henry M Blumberg; William J Burman; Richard E Chaisson; Charles L Daley; Sue C Etkind; Lloyd N Friedman; Paula Fujiwara; Malgosia Grzemska; Philip C Hopewell; Michael D Iseman; Robert M Jasmer; Venkatarama Koppaka; Richard I Menzies; Richard J O'Brien; Randall R Reves; Lee B Reichman; Patricia M Simone; Jeffrey R Starke; Andrew A Vernon
Journal:  Am J Respir Crit Care Med       Date:  2003-02-15       Impact factor: 21.405

2.  Atypical forms of spinal tuberculosis.

Authors:  K M Al-Arabi; F A Khan
Journal:  Acta Neurochir (Wien)       Date:  1987       Impact factor: 2.216

3.  Tuberculous spondylitis (Pott's disease) with bilateral pleural effusion.

Authors:  Y Okuyama; Y Nakaoka; K Kimoto; K Ozasa
Journal:  Intern Med       Date:  1996-11       Impact factor: 1.271

4.  Rate of reinfection tuberculosis after successful treatment is higher than rate of new tuberculosis.

Authors:  Suzanne Verver; Robin M Warren; Nulda Beyers; Madalene Richardson; Gian D van der Spuy; Martien W Borgdorff; Donald A Enarson; Marcel A Behr; Paul D van Helden
Journal:  Am J Respir Crit Care Med       Date:  2005-04-14       Impact factor: 21.405

5.  Tuberculosis of the spine: experience in an inner city hospital.

Authors:  Naomi Schlesinger; Alfred Lardizabal; Jayanti Rao; Jyoti Rao; Reynard McDonald
Journal:  J Clin Rheumatol       Date:  2005-02       Impact factor: 3.517

6.  Tuberculosis then and now: a personal perspective on the last 50 years.

Authors:  G L Snider
Journal:  Ann Intern Med       Date:  1997-02-01       Impact factor: 25.391

7.  Spinal tuberculosis: a diagnostic and management challenge.

Authors:  E S Nussbaum; G L Rockswold; T A Bergman; D L Erickson; E L Seljeskog
Journal:  J Neurosurg       Date:  1995-08       Impact factor: 5.115

8.  Spinal tuberculosis: atypical observations at MR imaging.

Authors:  J Ahmadi; A Bajaj; S Destian; H D Segall; C S Zee
Journal:  Radiology       Date:  1993-11       Impact factor: 11.105

9.  Prevalence and its predictors of extrapulmonary involvement in patients with pulmonary tuberculosis.

Authors:  Min Jae Kim; Hye-Ryoun Kim; Seung Sik Hwang; Young Whan Kim; Sung Koo Han; Young-Soo Shim; Jae-Joon Yim
Journal:  J Korean Med Sci       Date:  2009-04-20       Impact factor: 2.153

  9 in total
  1 in total

Review 1.  Mediastinal tuberculous lymphadenitis presenting with insidious back pain in a male adult: a case report and review of the literature.

Authors:  Xuli Ren; Kai Li; Longyun Li; Guoqing Zhao
Journal:  J Int Med Res       Date:  2021-01       Impact factor: 1.671

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.